Phenotypic variability of osteogenesis imperfecta type V caused by an IFITM5 mutation
- PMID: 23408678
- PMCID: PMC3688672
- DOI: 10.1002/jbmr.1891
Phenotypic variability of osteogenesis imperfecta type V caused by an IFITM5 mutation
Abstract
In a large cohort of osteogenesis imperfecta type V (OI type V) patients (17 individuals from 12 families), we identified the same mutation in the 5' untranslated region (5'UTR) of the interferon-induced transmembrane protein 5 (IFITM5) gene by whole exome and Sanger sequencing (IFITM5 c.-14C > T) and provide a detailed description of their phenotype. This mutation leads to the creation of a novel start codon adding five residues to IFITM5 and was recently reported in several other OI type V families. The variability of the phenotype was quite large even within families. Whereas some patients presented with the typical calcification of the forearm interosseous membrane, radial head dislocation and hyperplastic callus (HPC) formation following fractures, others had only some of the typical OI type V findings. Thirteen had calcification of interosseous membranes, 14 had radial head dislocations, 10 had HPC, 9 had long bone bowing, 11 could ambulate without assistance, and 1 had mild unilateral mixed hearing loss. The bone mineral density varied greatly, even within families. Our study thus highlights the phenotypic variability of OI type V caused by the IFITM5 mutation.
Copyright © 2013 American Society for Bone and Mineral Research.
Figures
Comment in
-
Osteogenesis imperfecta, an ever-expanding conundrum.J Bone Miner Res. 2013 Jul;28(7):1519-22. doi: 10.1002/jbmr.1982. J Bone Miner Res. 2013. PMID: 23696068 No abstract available.
Similar articles
-
The IFITM5 mutation c.-14C > T results in an elongated transcript expressed in human bone; and causes varying phenotypic severity of osteogenesis imperfecta type V.BMC Musculoskelet Disord. 2014 Mar 27;15:107. doi: 10.1186/1471-2474-15-107. BMC Musculoskelet Disord. 2014. PMID: 24674092 Free PMC article.
-
A mutation in the 5'-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus.Am J Hum Genet. 2012 Aug 10;91(2):349-57. doi: 10.1016/j.ajhg.2012.06.011. Epub 2012 Aug 2. Am J Hum Genet. 2012. PMID: 22863195 Free PMC article.
-
IFITM5 pathogenic variant causes osteogenesis imperfecta V with various phenotype severity in Ukrainian and Vietnamese patients.Hum Genomics. 2019 Jun 3;13(1):25. doi: 10.1186/s40246-019-0209-3. Hum Genomics. 2019. PMID: 31159867 Free PMC article.
-
IFITM5 mutations and osteogenesis imperfecta.J Bone Miner Metab. 2016 Mar;34(2):123-31. doi: 10.1007/s00774-015-0667-1. Epub 2015 Jun 2. J Bone Miner Metab. 2016. PMID: 26031935 Review.
-
A novel Ser40Trp variant in IFITM5 in a family with osteogenesis imperfecta and review of the literature.Clin Dysmorphol. 2019 Jul;28(3):120-125. doi: 10.1097/MCD.0000000000000279. Clin Dysmorphol. 2019. PMID: 30985308 Review.
Cited by
-
The IFITM5 mutation in osteogenesis imperfecta type V is associated with an ERK/SOX9-dependent osteoprogenitor differentiation defect.J Clin Invest. 2024 Jun 17;134(15):e170369. doi: 10.1172/JCI170369. J Clin Invest. 2024. PMID: 38885336 Free PMC article.
-
The novel role of IFITM1-3 in myogenic differentiation of C2C12 cells.Intractable Rare Dis Res. 2023 Aug;12(3):180-190. doi: 10.5582/irdr.2023.01050. Intractable Rare Dis Res. 2023. PMID: 37662621 Free PMC article.
-
Mesenchymal stem cells in the treatment of osteogenesis imperfecta.Cell Regen. 2023 Feb 2;12(1):7. doi: 10.1186/s13619-022-00146-3. Cell Regen. 2023. PMID: 36725748 Free PMC article. Review.
-
A Patient with Bone Fragility, Multiple Fractures, Osteosarcoma, and the Variant c.143A>G in the IFITM5 Gene: A Case Report.Orthop Res Rev. 2022 Nov 28;14:453-458. doi: 10.2147/ORR.S385146. eCollection 2022. Orthop Res Rev. 2022. PMID: 36467431 Free PMC article.
-
Does the c.-14C>T Mutation in the IFITM5 Gene Provide Identical Phenotypes for Osteogenesis Imperfecta Type V? Data from Russia and a Literature Review.Biomedicines. 2022 Sep 22;10(10):2363. doi: 10.3390/biomedicines10102363. Biomedicines. 2022. PMID: 36289625 Free PMC article.
References
-
- Shapiro JR, Sponsellor PD. Osteogenesis imperfecta: questions and answers. Curr Opin Pediatr. 2009;21(6):709–16. - PubMed
-
- Rauch F, Glorieux FH. Osteogenesis imperfecta. Lancet. 2004;363(9418):1377–85. - PubMed
-
- Glorieux FH, Rauch F, Plotkin H, Ward L, Travers R, Roughley P, Lalic L, Glorieux DF, Fassier F, Bishop NJ. Type V osteogenesis imperfecta: a new form of brittle bone disease. J Bone Miner Res. 2000;15(9):1650–8. - PubMed
-
- Brenner RE, Schiller B, Pontz BF, Lehmann H, Teller WM, Spranger J, Vetter U. [Osteogenesis imperfecta in childhood and adolescence] Monatsschr Kinderheilkd. 1993;141(12):940–5. German. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
